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The Pseudomonas syringae type III protein secretion system (T3SS) and the type III effectors it injects into plant
cells are required for plant pathogenicity and the ability to
elicit a hypersensitive response (HR). The HR is a programmed cell death that is associated with effector-triggered immunity (ETI). A primary function of P. syringae
type III effectors appears to be the suppression of ETI and
pathogen-associated molecular pattern–triggered immunity
(PTI), which is induced by conserved molecules on microorganisms. We reported that seven type III effectors from
P. syringae pv. tomato DC3000 were capable of suppressing
an HR induced by P. fluorescens(pHIR11) and have now
tested 35 DC3000 type III effectors in this assay, finding
that the majority of them can suppress the HR induced by
HopA1. One newly identified type III effector with particularly strong HR suppression activity was HopS2. We used
the pHIR11 derivative pLN1965, which lacks hopA1, in
related assays and found that a subset of the type III effectors that suppressed HopA1-induced ETI also suppressed
an ETI response induced by AvrRpm1 in Arabidopsis
thaliana. A. thaliana plants expressing either HopAO1 or
HopF2, two type III effectors that suppressed the HopA1induced HR, were reduced in the flagellin-induced PTI response as well as PTI induced by other PAMPs and allowed
enhanced in planta growth of P. syringae. Collectively, our
results suggest that the majority of DC3000 type III effectors can suppress plant immunity. Additionally, the construct pLN1965 will likely be a useful tool in determining
whether other type III effectors or effectors from other
types of pathogens can suppress either ETI, PTI, or both.
Pseudomonas syringae is a gram-negative bacterial plant
pathogen that requires a type III protein secretion system
(T3SS) and the type III effectors that it injects into plant cells
to be pathogenic. The T3SS in P. syringae is encoded by hypersensitive response and pathogenicity (hrp) and hrp conserved (hrc) genes in the Hrp pathogenicity island (Alfano et
al. 2000; Collmer et al. 2000). The T3SS injects type III effectors into host cells in which they contribute to disease in susceptible plants, primarily by suppression of plant innate immuMing Guo and Fang Tian contributed equally to this work.
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nity (Abramovitch et al. 2006; Espinosa and Alfano 2004). In
resistant plants however, type III effectors can be recognized
by plant resistance (R) proteins inducing effector-triggered
immunity (ETI), which includes the elicitation of the hypersensitive response (HR), a programmed cell death in plants.
ETI makes up one of the two branches of the innate immune
system of plants (Jones and Dangl 2006).
The other branch of the plant innate immune system is activated by recognition of pathogen-associated molecular patterns
(PAMPs) and is referred to as PAMP-triggered immunity (PTI)
(Nurnberger et al. 2004; Zipfel 2008). PAMPs are present in
pathogenic and nonpathogenic microorganisms and are also
referred to as microbe-associated molecular patterns (MAMPs)
(Ausubel 2005). One of the PAMPs whose role in inducing PTI
is best understood is bacterial flagellin, which is recognized by
the Arabidopsis thaliana receptor kinase FLS2 (Gomez-Gomez
and Boller 2000; Zipfel et al. 2004). FLS2 also recognizes a
conserved peptide of flagellin, flg22, that is often used in assays
to induce outputs of PTI, including callose (β-1,3 glucan) deposition in the plant cell wall (Gomez-Gomez et al. 1999).
In 1988, a paper reported a cosmid named pHIR11 that contained a cluster of hrp/hrc genes from P. syringae pv. syringae
61 that, when expressed in saprophytes such as P. fluorescens,
conferred upon them the ability to elicit an HR in tobacco
(Huang et al. 1988). This predated the discovery that hrp/hrc
genes encoded a T3SS, but it proved to be a useful tool to explore the function of these genes in P. syringae. For example,
pHIR11 was instrumental in identifying the first protein found
to be secreted by the P. syringae T3SS (HrpZ1) (He et al.
1993). At that time, HrpZ1 was thought to be responsible for
the HR elicited by P. syringae because it was encoded by
pHIR11, it was a type III–secreted protein, and purified HrpZ1
infiltrated into tobacco leaves elicited an HR. However, it was
subsequently determined that a nonpolar insertion in hrpZ1 in
pHIR11 retained the ability to elicit an HR when expressed in
P. fluorescens (Alfano et al. 1996). Thus, even though purified
HrpZ1 elicited an HR, it was unlikely to be the elicitor of the
bacterial-induced HR. This realization led to the discovery that
HopA1 (formerly HrmA and HopPsyA) was the type III
effector encoded by pHIR11 that was responsible for the
pHIR11-induced HR and that HopA1 needed to be inside plant
cells to elicit the HR (Alfano et al. 1997).
We have used pHIR11 as a tool to elucidate different components of the T3SS. For example, we used pHIR11 to help
show that HopA1 required the ShcA type III chaperone to be
secreted via the T3SS (van Dijk et al. 2002). Importantly, for
the research we describe here, we previously used P. fluoresVol. 22, No. 9, 2009 / 1069

cens(pHIR11) in an assay in which we also expressed newly
discovered type III effectors from P. syringae pv. tomato
DC3000, to determine whether they could suppress the
pHIR11-dependent HR. Remarkably, we found that seven of
the 19 DC3000 type III effectors tested could fully or partially
suppress the pHIR11-dependent HR (Jamir et al. 2004).
pHIR11 has also been used to show that Xanthomonas campestris pv. vesicatoria type III effectors could also suppress
HopA1-induced ETI (Fujikawa et al. 2006). Thus, pHIR11 has
proved to be a simple and effective tool to increase our understanding of the T3SS in bacterial plant pathogens.
We modified pHIR11 by substituting hopA1 with a kanamycin-resistance cassette, resulting in construct pLN18 (Jamir et
al. 2004). This construct allowed us to perform bacterial mixing experiments to show that a type III effector could suppress
ETI, even when delivered by a different bacterial strain from
the one injecting the recognized type III effector (Jamir et al.
2004). Because P. fluorescens(pLN18) does not inject any type
III effector but does contain PAMPs and induces PTI, this
strain was used to show that a number of DC3000 type III
effectors could suppress a PTI output (Oh and Collmer 2005).
Here, we test 35 DC3000 type III effectors for their ability
to suppress pHIR11-dependent ETI and find that the majority
are capable of ETI suppression. We also show that the well-

Table 1. DC3000 type III effectors tested for their ability to suppress a
HopA1-dependent hypersensitive response (HR) in tobacco elicited by
Pseudomonas fluorescens(pHIR11)
Type III effectors

Plasmid

Suppression classa

AvrE
AvrPto
AvrPtoB
HopA1
HopB1
HopC1
HopD1
HopE1
HopF2
HopG1
HopH1
HopI1
HopK1
HopM1
HopN1
HopO1-1
HopO1-2
HopQ1-1
HopR1
HopS2
HopT1-1
HopT1-2
HopU1
HopV1
HopX1
HopY1
HopAA1-1
HopAA1-2
HopAD1
HopAF1
HopAI1
HopAM1
HopAN1
HopAO1
HopAQ1
HopAS1′

pLN2423
pLN1327
pLN347
pLN1326
pLN271
pLN50
pLN167
pLN162
pLN1420
pLN460
pLN150

II
II
I
II
IV
III
I
I
I
II
II
Not tested
I
II
II
II
II
III
II
I
III
III
II
II
I
II
III
II
III
II
IV
I
II
II
II
IV

a

pCPP5100
pLN1156
pLN1324
pLN1622
pLN1623
pLN518
pLN1154
pLN1624
pLN256
pLN567
pLN223
pLN517
pCPP5068
pLN1528
pLN1326
pLN1419
pLN165
pLN164
pLN1011
pCPP5063
pLN1329
pLN130
pLN1331
pLN1328

Class I suppressors are type III effectors that suppressed the HopA1dependent HR at 1 × 108 cells/ml; class II completely suppressed the HR
at 2 × 107 cells/ml; class III suppressors are type III effectors that were
variable in their ability to suppress the HopA1-dependent HR at 2 × 107
cells/ml; and class IV contains type III effectors that were unable to suppress the HR at 2 × 107 cells/ml.
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characterized type III effectors AvrRpm1 and AvrRpt2 are also
capable of suppressing pHIR11-dependent ETI. We made a derivative of pHIR11 named pLN1965 that substituted hopA1
with a spectinomycin-resistance cassette. P. fluorescens
(pLN1965) separately expressing different DC3000 type III
effectors also suppressed the AvrRpm1-dependent ETI as well
as PTI in Arabidopsis thaliana. Taken together, our data indicate that the vast majority of the DC3000 type III effectors can
suppress ETI and that many of them can also suppress PTI.
This suggests that either common targets for type III effectors
are utilized in pathways needed for both ETI and PTI, that
many type III effectors have multiple activities, or both. Additionally, construct pLN1965 will likely be useful for testing
whether other type III effectors and effectors from other types
of plant pathogens can suppress plant immunity.
RESULTS
Screening the DC3000 type III effector inventory
for suppressors of the HopA1 effector-triggered HR.
The cosmid pHIR11 encodes a functional T3SS and one
type III effector HopA1 (Alfano and Collmer 1997; Lindeberg
et al. 2005; van Dijk et al. 1999). We previously used this cosmid to screen DC3000 type III effectors for their ability to
suppress the HopA1-induced HR when expressed in P. fluorescens (Jamir et al. 2004). Nineteen type III effectors were
screened, and five, AvrPtoB (HopAB2), HopE1, HopF2, HopX1
(AvrPphE), and HopAM1 (AvrPpiB1), were capable of completely suppressing the HopA1-induced HR, while two others,
HopD1 and HopK1, had an intermediate ability to suppress
this HR (Jamir et al. 2004).
If the DC3000 type III effector inventory is limited to type
III effectors that have been confirmed or to those for which
there exists experimental evidence supporting that they are
type III effectors, there are 36 type III effectors present in
DC3000 (Lindeberg et al. 2005, 2006). We tested the remaining 29 DC3000 type III effectors in the P. fluorescens(pHIR11)
assay with the exception of HopI1, due to difficulties in the
isolation of its gene. Type III effector genes were cloned into
pLN615 and were transformed into P. fluorescens(pHIR11).
Each strain expressing individual type III effectors was infiltrated into tobacco leaves at a cell density of 1 × 108 cells/ml
and was examined for its ability to suppress the HopA1-dependent HR by comparing each test strain with a control strain on
the same leaf. Surprising, only one additional type III effector,
HopS2, was capable of completely suppressing the HopA1dependent HR at this cell density (Fig. 1). The suppression
activity of HopS2 required the presence of the HopS2 cognate
type III chaperone, which has been shown to be required for
HopS2 to be secreted via the T3SS (Guo et al. 2005).
Based on the number of type III effectors that possessed
suppressor activity in our earlier study (Jamir et al. 2004), we
expected that many more of the remaining DC3000 type III
effectors would be capable of suppressing the HopA1-dependent HR. We speculated that our assays may have failed to detect additional DC3000 type III effectors capable of suppressing the HR because the cell densities used far exceeded the
threshold cell density needed for HR elicitation and this may
have left unidentified type III effectors that possessed less-substantial suppressor activity. P. fluorescens(pHIR11) maintains
its ability to elicit a consistent confluent HR at a cell density of
2 × 107 cells/ml and, therefore, we retested all of the type III
effectors at this cell density. When DC3000 type III effectors
were retested in the P. fluorescens(pHIR11) system at the
lower cell density, the vast majority of them were able to suppress the HopA1-dependent HR (Table 1). To distinguish between the different levels of HR suppression activity displayed

by different type III effectors, we separated them into different
suppressor classes: Class I suppressors were type III effectors
that suppressed the HopA1-dependent HR at 1 × 108 cells/ml,
class II completely suppressed the HR at 2 × 107 cells/ml,
class III contained type III effectors that were variable in their
7
ability to suppress the HopA1-dependent HR at 2 × 10 cells/ml,
and class IV contained type III effectors that were unable to
suppress the HR at 2 × 107 cells/ml. Class I contained eight
type III effectors, class II contained 18 type III effectors, class
III contained six type III effectors, and class IV contained
three type III effectors.
Two well-studied type III effectors, AvrRpm1 and AvrRpt2,
can also suppress the HR induced by HopA1.
Much is known about the activities and targets for the type
III effectors AvrRpm1 and AvrRpt2 (Axtell and Staskawicz.
2003; Kim et al. 2005; Mackey et al. 2002, 2003). We tested
whether these type III effectors were capable of suppressing
the HR elicited by P. fluorescens(pHIR11) in experiments similar to the ones described above. The control strain elicited an
HR at densities of 1 × 108 and 2 × 107 cells/ml, whereas strains
harboring pVSP61::avrRpm1 and pLN1906, which expressed
AvrRpm1 and AvrRpt2, respectively, did not elicit an HR at
these cell densities (Fig. 2). Thus, both AvrRpm1 and AvrRpt2
strongly suppressed the HopA1-dependent HR in tobacco and,

by the classification used in Table 1, would both be considered
class I suppressors. AvrRpm1 and AvrRpt2 have been reported
to suppress PTI (Kim et al. 2005). Our results indicate that
AvrRpm1 and AvrRpt2 can also suppress a HopA1-dependent
ETI response, consistent with earlier reports indicating that
these type III effectors could interfere with AvrRpm1-dependent
and AvrRpt2-dependent ETI responses (Reuber and Ausubel
1996; Ritter and Dangl 1996).
Testing type III effector suppression of other ETI responses
using a modified pHIR11 system.
In our earlier report, we modified pHIR11 by replacing
hopA1 with a kanamycin-resistance cassette resulting in
pLN18, which encodes a functional T3SS and allows for the
injection of other effectors into plant cells when expressed in
P. fluorescens. However, P. fluorescens(pLN18) is limited because it uses kanamycin resistance to maintain pLN18. This is
significant because P. fluorescens 55 is resistant to most of the
other antibiotics commonly used to select for broad-host-range
plasmids. To address this issue, we made a derivative of
pLN18 in which the kanamycin-resistance cassette is replaced
with a spectinomycin-resistance cassette resulting in construct
pLN1965. P. fluorescens(pLN1965) allowed us to test whether
other ETI responses were also suppressed by the type III effector that suppressed the HopA1-dependent HR. We introduced

Fig. 1. The Pseudomonas syringae pv. tomato DC3000 type III effector HopS2 can suppress the HopA1-dependent hypersensitive response (HR) elicited by
P. fluorescens(pHIR11). P. fluorescens(pHIR11) strains carrying a control vector, pLN1624 (pshcS2 + hopS2) containing hopS2 with its type III chaperone
gene shcS2, or pLN452 (phopS2) expressing hopS2 alone were infiltrated into Nicotiana tabacum cv. Xanthi leaves at a cell density of 1 × 108 or 2 × 107
cells/ml. The leaves were evaluated for production of a HR and were photographed after 48 h. The ability of HopS2 to suppress the HopA1-dependent HR
was dependent on the presence of its cognate type III chaperone ShcS2. This experiment was repeated 10 times with similar results.

Fig. 2. Pseudomonas syringae type III effectors AvrRpm1 and AvrRpt2 can suppress the HopA1-dependent hypersensitive response (HR) in tobacco. P.
fluorescens(pHIR11) strains carrying constructs pVSP61::avrRpm1 (pavrRpm1), pLN1906 (pavrRpt2), or a vector control were infiltrated into Nicotiana
tabacum cv. Xanthi leaves. P. fluorescens(pHIR11) carrying a vector control elicits a HR at the rate of 1 × 108 and 2 × 107 cells/ml, whereas the HR is
suppressed in the P. fluorescens(pHIR11) strains expressing avrRpm1 or avrRpt2, indicating that AvrRpm1 and AvrRpt2 can suppress the HopA1-dependent
HR. Tobacco leaves were evaluated for the development of the HR and were photographed 48 h after infiltration.
Vol. 22, No. 9, 2009 / 1071

avrRpm1 on a broad-host-range plasmid into P. fluorescens
(pLN1965), also carrying compatible plasmids that encoded
either HopE1, HopF2, AvrPtoB, HopAM1, or HopX1 and infiltrated each of these strains into A. thaliana Col-0. AvrRpm1 is
recognized by R protein RPM1 present in this accession of A.
thaliana, inducing ETI (Grant et al. 1995). All of these type III
effectors were capable of suppressing the AvrRpm1-dependent
HR (Fig. 3A). Callose deposition in the plant cell wall is another
output of ETI. Using the same strains, we determined that each
of these type III effectors was capable of reducing the amount
of AvrRpm1-dependent callose deposition (Fig. 3B and C),
indicating that these type III effectors can suppress multiple
outputs of ETI.
Class I HR suppressors can also inhibit
callose deposition induced by P. fluorescens PAMPs.
P. fluorescens(pLN1965) does not elicit an HR because it
does not inject any type III effectors. However, it does contain
flagellin and likely other PAMPs that are recognized by plants

that lead to PTI. We found that when P. fluorescens(pLN1965)
was infiltrated into A. thaliana Col-0 leaves, it induces callose
deposition (Fig. 4), which is likely due to the recognition of P.
fluorescens PAMPs. We infiltrated P. fluorescens(pLN1965)
expressing either AvrPtoB, HopE1, HopF2, HopX1, or
HopAM1 into A. thaliana Col-0 leaves, to test whether they
were able to suppress callose deposition induced by P. fluorescens(pLN1965). Indeed, in each case, the callose deposition
was reduced compared with that in a control strain (Fig. 4).
Taken together, the ability of type III effectors to suppress callose deposition induced by both AvrRpm1 and P. fluorescens
(pLN1965) suggests that either ETI and PTI responses overlap
in their signaling pathways or that type III effectors can
separately target unique components in each pathway, or both.
HopAO1 and HopF2 suppress flg22-induced
innate immunity.
To further study the suppression of innate immunity by type
III effectors, we chose to make transgenic A. thaliana Col-0

Fig. 3. Modification of the Pseudomonas fluorescens(pHIR11) system shows that a subset of type III effectors that are class I suppressors can also suppress
the AvrRpm1-dependent effector-triggered immunity. A, Arabidopsis thaliana ecotype Col-0 leaves were infiltrated with P. fluorescens(pLN1965)(pavrRpm1)
strains carrying an empty vector (pBBR1MCS5) or constructs that expressed different type III effectors known to suppress the HopA1-dependent hypersensitive response (HR). In each case, the type III effector was also capable of suppressing the AvrRpm1-dependent HR. B, A. thaliana ecotype Col-0 leaves were
infiltrated with P. fluorescens(pLN1965)(pavrRpm1) strains carrying an empty vector (pBBR1MCS5) or constructs that expressed different type III effectors
known to suppress the HopA1-dependent HR. Callose deposition induced by AvrRpm1 was suppressed in strains that expressed a type III effector known to
suppress the HopA1-dependent HR. Leaves were microscopically viewed for evidence of callose deposition 16 h after infiltration.C, Callose deposits shown
in B were quantified, and the average of 20 views of fields from five leaves and standard errors are shown.
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plants that express either the class I suppressor HopF2 or the
class II suppressor HopAO1. We have previously shown that
HopAO1 (formally HopPtoD2) and HopF2 were capable of
suppressing an HR response induced by an avirulent P. syringae strain or HopA1 (Espinosa et al. 2003; Jamir et al. 2004).
We made several independent transgenic A. thaliana Col-0 lines
that express HopAO1 or HopF2 fused to the hemagglutinin
(HA) epitope under control of the constitutive Cauliflower
mosaic virus 35S promoter. We confirmed that these lines expressed HopAO1-HA or HopF2-HA (Fig. 5A). When a conserved 22–amino acid peptide (flg22) from flagellin is infiltrated into A. thaliana, it induces PTI responses, which include
callose deposition, alkalization, and an oxidative burst in a
manner dependent on the FLS2 receptor kinase (Felix et al.
1999; Gomez-Gomez and Boller 2000; Gomez-Gomez et al.
1999). When 1 μM flg22 was infiltrated into transgenic plants
expressing HopAO1-HA or HopF2-HA, they showed significantly reduced callose deposition compared with wild-type A.
thaliana Col-0 plants (Fig. 5A and B). An inactive flg22At peptide derived from Agrobacterium flagellin was used as a control in these experiments, since this peptide is known not to
induce high levels of callose deposition. Thus, both HopAO1
and HopF2 exhibited the ability to suppress flg22-induced callose deposition in A. thaliana.
Another way to test whether plants expressing HopAO1-HA
and HopF2-HA were capable of suppressing PTI-dependent callose deposition is to infiltrate a P. syringae type III–defective
mutant (Hauck et al. 2003). Since a type III–defective mutant is
unable to inject any type III effectors, any PAMP recognized by
the plant results in PTI. We infiltrated a P. syringae pv. tomato
DC3000 hrcC mutant defective in type III secretion into transgenic plants expressing HopAO1-HA or HopF2-HA and examined callose deposition 16 h postinfiltration. The numbers of callose deposits were significantly reduced in the HopAO1-HA or
HopF2-HA transgenic plants compared with wild-type plants
(Fig. 5C). This result suggests that HopAO1 and HopF2 can
suppress PAMP-induced callose deposition and is consistent
with their ability to suppress flg22-induced PTI.

We determined how much of the callose deposition induced
by the DC3000 hrcC mutant was due to recognition of flagellin by constructing a DC3000 hrcC fliR double mutant. The
fliR gene encodes a protein in the flagellar basal body that is
required for flagellar biogenesis (Fan et al. 1997; Kubori et al.
1997). We infiltrated the DC3000 hrcC fliR double mutant into
wild-type A. thaliana and found that it induced less than half
the number of callose foci than did the DC3000 hrcC single
mutant (Fig. 5C), suggesting that flagellin is a major PAMP in
P. syringae–plant interactions. We also infiltrated the DC3000
hrcC fliR mutant into A. thaliana Col-0 plants expressing either
HopF2-HA or HopAO1-HA and found the residual callose
deposition induced by the hrcC fliR mutant was suppressed in
these plants (Fig. 5C), indicating that these type III effectors
can suppress PTI induced by PAMPs other than flagellin.
DC3000 and a DC3000 type III-defective mutant grows
to higher levels in A. thaliana plants
expressing HopAO1-HA or HopF2-HA.
If plants expressing HopAO1-HA or HopF2-HA have a reduced PTI response, we thought they may be less able to defend themselves against P. syringae. To test this, we sprayinoculated DC3000 or the DC3000 hrcC mutant into wild type
and A. thaliana plants expressing HopAO1-HA or HopF2-HA
and determined how well each strain grew in these plants.
DC3000 grew to higher levels in plants expressing either
HopAO1-HA or HopF2-HA (Fig. 6A). Pretreatment with flg22
slightly reduced DC3000 growth in all plant lines when compared with the corresponding untreated plants (Fig. 6B). However, the expression of HopAO1-HA or HopF2-HA allowed
increased DC3000 growth with or without flg22 pretreatment,
suggesting that the PTI response is not completely suppressed
by DC3000 type III effectors. Additionally, growth of DC3000
in type III effector–expressing plants pretreated with flg22 was
reduced compared with untreated type III effector–expressing
plants, which suggests that the PTI response was not completely
suppressed by the in planta overexpression of these type III
effectors.

Fig. 4. Type III effectors belonging to the class I suppressor group can suppress callose deposition induced by pathogen-associated molecular pattern
(PAMP)–triggered immunity. A, Arabidopsis thaliana ecotype Col-0 leaves were infiltrated with Pseudomonas fluorescens(pLN1965) strains carrying an
empty vector (pBBR1MCS5) or constructs that expressed different type III effectors known to suppress the HopA1-dependent hypersensitive response.
These type III effectors can suppress callose deposition triggered by PAMPs presented by P. fluorescens(pLN1965). Leaves were microscopically viewed for
evidence of callose deposition 16 h after infiltration. B, Callose deposits shown in A were quantified, and the average of 20 views of fields from five leaves is
shown. Each experiment was repeated three times with similar results, and the standard errors are indicated in the bar graphs.
Vol. 22, No. 9, 2009 / 1073

The DC3000 hrcC mutant normally has restricted growth in
planta, likely due to the induction of PTI and the inability of
this mutant to suppress it by injecting type III effectors.
Therefore, in planta growth assays using the hrcC mutant is
another measure of PTI suppression (Hauck et al. 2003). In
our experiments, the hrcC mutant accumulated to approximately 300-fold higher levels in A. thaliana plants expressing
either HopAO1-HA or HopF2-HA compared with wild-type A.
thaliana Col-0 plants (Fig. 6C). Taken together, these results
suggest that both HopAO1 and HopF2 suppress PTI and ETI
responses and this suppression allows the pathogen to grow
better in plants.
DISCUSSION

Fig. 5. Transgenic Arabidopsis thaliana plants expressing the HopAO1 or
HopF2 type III effectors were reduced in pathogen-associated molecular
pattern–triggered callose deposition. A, Callose deposition was visualized
in wild-type A. thaliana Col-0 plants or in plants expressing HopAO1 hemagglutinin (HA) or HopF2-HA 16 h after treatment with flg22 or flg22At,
an inactive peptide from Agrobacterium flagellin. Immunoblots were carried out using anti-HA antibody on leaf tissue samples from plants used in
the experiment, to confirm that HopAO1-HA and HopF2-HA were produced. B, Callose deposition in plants depicted in A was quantified by
counting the number of callose foci per field of view. C, Callose deposition induced by a DC3000 hrcC mutant (defective in the ype III protein
secretion system) or a DC3000 hrcC fliR (defective in flagellar biogensis)
double mutant was quantified as noted in B. The numbers of callose foci
in B and C are averages of 20 fields of view (four views per leaf samples)
and standard errors are shown. All experiments were repeated three times
with similar results.
1074 / Molecular Plant-Microbe Interactions

In this report, we tested 35 DC3000 type III effectors for
their ability to suppress the HopA1-dependent HR using P.
fluorescens carrying cosmid pHIR11, which encodes a
functional T3SS and one type III effector HopA1. The pHIR11
system was first used to assay for type III effectors that suppress the HR by Jamir and associates (2004). This earlier report tested 19 DC3000 type III effectors and identified seven
that could suppress the HopA1-dependent HR. Here, we have
extended this assay to include the complete DC3000 inventory
of confirmed and likely type III effectors (Lindeberg et al.
2006), with the only exception being HopI1.
Based on our earlier results, we were expecting many more
DC3000 type III effectors to completely suppress the HopA1dependent HR when P. fluorescens (pHIR11) was infiltrated
into tobacco at a cell density of 1 × 108 cells/ml. However, we
identified only one additional DC3000 type III effector capable of HR suppression at this titer. This prompted us to infiltrate plants with bacteria at a cell density closer to the threshold cell density needed for production of a macroscopic HR
and, when we did so, the majority of the DC3000 type III effectors possessed substantial HR suppression activity (Table 1).
Each DC3000 type III effector was assigned to one of four
different classes of HR suppressor, and there were only a few
cases in which we were unable to detect any suppression of the
HopA1-dependent HR.
The newly identified DC3000 type III effector as a class I
suppressor was HopS2. Other than some similarity in its N-terminal secretion signal with HopS1’, HopS2 has no obvious
similarity with any proteins in the databases (Guo et al. 2005).
We showed earlier that hopS2 was expressed in conditions that
induce expression of the T3SS and that HopS2 is injected into
plant cells in a manner dependent on its type III chaperone
ShcS2 (Guo et al. 2005). Based on a limited study, hopS2 appeared to be well distributed in different P. syringae pathovars
(Guo et al. 2005). The fact that this type III effector possesses
particularly strong HR suppressor activity makes it an attractive type III effector to study further, to identify its plant targets. Our HR suppressor screen also included the well-characterized type III effectors AvrRpm1 and AvrRpt2 from other P.
syringae strains, which were found also to be class I HR suppressors (Fig. 2). Both of these type III effectors are known to
target RIN4 (Axtell and Staskawicz 2003; Mackey et al. 2003).
RIN4 associates with RPM1 and RPS2, the R proteins that recognize AvrRpm1 and AvrRpt2, respectively, and modification
of RIN4 appears to lead to induction of ETI. It would be of
interest to know if the HopA1-dependent ETI response is also
dependent on RIN4. Whatever the case, because of their similarly strong ability to suppress HopA1-induced ETI, it is possible that the type III effectors that make-up class I suppressors
target related innate immunity components.
We modified cosmid pHIR11 to allow us to test whether a
subset of the class I HR suppressors could also suppress the

HR induced by a different type III effector. This pHIR11 derivative, pLN1965, still encodes a functional T3SS but lacks
hopA1. Using P. fluorescens (pLN1965), we showed that the
type III effectors HopE1, HopF2, AvrPtoB, HopAM1, and
HopX1, which were class I suppressors, all were capable of
suppressing the AvrRpm1-dependent HR and callose deposition in A. thaliana Col-0 (Fig. 3). Because P. fluorescens(pLN1965) does not inject any type III effectors that induce ETI but does induce PTI, this system also allowed us to
demonstrate that these five type III effectors also suppressed
PTI-induced callose deposition (Fig. 4). In the majority of
published reports, P. syringae type III effectors have been
shown to suppress PTI or ETI, but both types of immunity
generally are not tested. The most notable exceptions to this
are the type III effectors AvrPtoB and HopAO1, which have
been shown to suppress both ETI and PTI (Abramovitch and
Martin 2005; Bretz et al. 2003; de Torres et al. 2006; Espinosa
et al. 2003; Rosebrock et al. 2007; Underwood et al. 2007).
The results from this study suggest that many P. syringae type
III effectors likely suppress both ETI and PTI, possibly because type III effectors have multiple plant targets or their
plant targets have roles in either one or both ETI and PTI.
We envision that P. fluorescens(pLN1965) will be useful for
researchers studying other type III effectors. For example, they
could use this system to screen whether the type III effectors
they are interested in induce ETI or suppress innate immunity.
Moreover, the system could be adapted for the identification of
effectors from other bacterial, oomycete, fungal, or viral pathogens. Recently oomycete effector genes were identified by
fusing candidate effector genes to nucleotide sequences corresponding to the N-terminal type III secretion signal of different P. syringae type III effectors (Rentel et al. 2008; Sohn et al.
2007). Expressing these fusion proteins in P. syringae allowed
them to be injected into plant cells via the T3SS, facilitating

the discovery of their in planta effects. However, studying
these heterologous effectors in the wild-type P. syringae background may mask some of their effects in plant cells, due to
the injection of many P. syringae type III effectors. We suggest
that performing analogous experiments using P. fluorescens
(pLN1965) may provide clearer plant phenotypes because this
system does not inject any other type III effectors that could
potentially mask interesting phenotypes. In addition, because
this strain does not grow well in plant tissue determining
whether a test effector contributes to in planta growth may be
made more clear.
To investigate two of the type III effectors in planta phenotypes in more detail, we made transgenic A. thaliana plants
that constitutively expressed a class I suppressor, HopF2, and a
class II suppressor, HopAO1. We found that transgenic expression of both of these type III effectors suppressed flg22induced PTI (Fig. 5). HopAO1 is a protein tyrosine phosphatase that has been previously shown to suppress a nonhost HR
and other ETI responses (Bretz et al. 2003; Espinosa et al.
2003), and more recently, it has been shown to suppress PTI
responses, using transgenic A. thaliana plants expressing
HopAO1 (Underwood et al. 2007). Our experiments reported
here with A. thaliana HopOA1-expressing plants essentially
confirm that these plants are suppressed in their PTI responses.
In our experiments, flg22 pretreatment still reduced the ability
of DC3000 to multiply in HopAO1-expressing plants compared with untreated plants. Thus, HopAO1 did not completely
suppress the PTI response in these plants, as it did in the earlier study.
The PTI response in A. thaliana plants expressing HopF2
was also suppressed based on the suppression of flg22-induced
callose deposition, and the increased growth of the DC3000
type III–defective hrcC mutant. Other reports have suggested
that HopF2 was capable of suppressing both ETI in tobacco

Fig. 6. Transgenic Arabidopsis thaliana plants expressing HopAO1 or HopF2 are more susceptible to Pseudomonas syringae and a type III–defective mutant
than is wild-type Arabidopsis. A, A. thaliana Col-0 plants were spray-inoculated with P. syringae pv. tomato DC3000. DC3000 was able to grow to higher
levels in plants expressing HopAO1 or HopF2 than in A. thaliana Col-0. B, A. thaliana Col-0 plants were pretreated with 1 μM flg22, and after 16 h, were
spray-inoculated with DC3000. Overall, the pretreatment with flg22 reduced bacterial growth comp plants ared with non-pretreated plants in A. DC3000
grew to higher levels on plants expressing HopAO1 and HopF2 than it did on A. thaliana Col-0. C, A. thaliana were spray-inoculated with a DC3000 hrcC.
The growth of the DC3000 hrcC mutant was enhanced in transgenic plants expressing HopAO1 or HopF2 as compared with wild-type Col-0. In all experiments, plants were inoculated at a cell density of 2 × 108 cells/ml, and bacteria were enumerated at days 0 and 4.
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and PTI in Nicotiana benthamiana when delivered by bacteria
(Jamir et al. 2004; Oh and Collmer 2005). Another report indicated that HopF2 and a number of other P. syringae type III
effectors were capable of suppressing flagellin-induced gene
expression in A. thaliana protoplasts (Li et al. 2005) consistent
with HopF2 suppressing PTI. The enzymatic activity of HopF2
and its plant targets are currently unknown. However, its
molecular structure has been determined, and one portion of it
shared limited structural similarity with ADP-ribosyltransferases, but this activity could not be demonstrated (Singer et al.
2004). The results described here further establish that HopF2
can suppress both ETI and PTI.
A DC3000 hrcC fliR double mutant was capable of inducing
callose deposition, although it was greatly reduced, indicating
that flagellin is a primary PAMP in A. thaliana Col-0. Transgenic A. thaliana plants expressing HopAO1 or HopF2 were
suppressed in their callose deposition in response to the DC3000
hrcC fliR double mutant, indicating that these type III effectors
suppressed PTI responses induced by PAMPs other than flagellin. This is consistent with the induction of PTI in A. thaliana
plants defective in FLS2, the receptor kinase that recognizes
flagellin, which suggests that additional bacterial PAMPs are
recognized by A. thaliana Col-0 (Zipfel et al. 2004). We now
know that one of these additional bacterial PAMPs is the translation elongation factor EF-Tu (Zipfel et al. 2006), but likely other
bacterial PAMPs and PAMP receptors await discovery.

Evolutionary models suggest that bacterial pathogens first
acquired type III effectors that suppressed only PTI (Chisholm
et al. 2006; Espinosa and Alfano 2004). The rationale behind
this is that the existence of PTI likely predated ETI and that
PTI probably was the primary selection for pathogens to initially acquire a T3SS and a minimal set of type III effectors.
The most logical place to look for genes encoding type III effectors that target PTI but not ETI is in the conserved effector
locus (CEL) within the Hrp pathogenicity island (Alfano et al.
2000) because these type III effectors genes are conserved in
all P. syringae strains tested and because acquiring an apparatus without type III effector genes would serve little benefit to
the pathogen. Interestingly, two conserved type III effector
genes within the CEL are avrE and hopM1 and both are class
II suppressors in HopA1-induced HR suppression assays, indicating that both were capable of suppressing ETI. These results suggest that these type III effectors either act on host targets needed for both PTI and ETI, or they contain multiple
activities, or both. Moreover, these results imply that the archetypal type III effectors may have also had the ability to suppress
both PTI and ETI, which suggests that HopM1 and AvrE1
target components used in both ETI and PTI.
Collectively our results indicate that the lion’s share of P. syringae type III effectors suppress plant innate immunity. However, they also illustrate the need for assays that report more
specifically the responses affected in the host as well as the

Table 2. Strains and plasmids used in this study
Characteristicsa

Strain or plasmid
E. coli
DH5α
DB3.1
C2110
Pseudomonas fluorescens 55
DC3000
DC3000 hrcC
UNL143
pBluescript-II KS+
pBBR1MCS5
pCPP5040
pCPP5063
pCPP5068
pCPP5100
pENTR/D-TOPO
pHIR11
pML123
pRK415
pVSP61::avrRpm1
pLN50
pLN130
pLN150
pLN162
pLN164
pLN165
pLN167
pLN223
pLN256
pLN271
pLN347
pLN452
pLN460
pLN462
pLN517
pLN518
pLN525
a

supE44 ΔlacU169(φ80lacZΔM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1, Nalr
F – gyrA462 endA1 Δ(sr1-recA) mcrB mrr hsdS20 (rB– , mB–) supE44 ara-14 galK2
lacY1 proA2 rpsL20 (Smr) xyl-5 λ– leu mtl-1
PolATS Nalr
Nalr
Wild type; spontaneous Rif r
hrcC mutant defective in T3SS, Cmr
DC3000 fliR hrcC double mutant, Cmr Spr
Cloning vector, Apr
Broad-host-range vector, Gmr
pML123-hemagglutinin (HA) derivative gateway destination vector, Gmr Cmr
pCPP5040 derivative carrying hopAM1, Gmr
pCPP5040 derivative carrying hopX1, Gmr
pCPP5040 derivative carrying hopK1, Gmr
Gateway system entry vector, Kmr
Cosmid pLAFR3 derivative carring genomic DNA of P. syringae pv. syringae 61, Tcr
Broad-host-range cloning vector, Gmr Kmr
Broad-host-range vector, unstable in absence of selection, Tcr
pVSP61 derivative carrying avrRpm1, Kmr
pML123 derivative carrying hopC1-flag, Gmr
pML123 derivative carrying hopAO1-ha, Gmr
pML123 derivative carrying hopH1-flag, Gmr
pML123 derivative carrying hopE1- flag, Gmr
pML123 derivative carrying hopAF1-flag, Gmr
pML123 derivative carrying hopAD1-flag, Gmr
pML123 derivative carrying hopD1-flag, Gmr
pML123 derivative carrying hopU1-flag, Gmr
pML123 derivative carrying hopT1-1-flag, Gmr
pML123 derivative carrying hopB1-flag, Gmr
pML123 derivative containing avrPtoB-ha, Gmr
pLN615 derivative containing hopS2, Gmr
pML123 derivative carrying hopG1-flag, Gmr
pPZP212 derivative gateway destination binary vector containing 35S promoter and
a HA tag for C-terminal fusions, Spr
pML123 derivative carrying shcV/hopV1-ha, Gmr
pML123 derivative carrying hopQ1-1-flag, Gmr
pLN462 derivative carrying hopF2, Spr

Reference or source
Hanahan 1983; Life Technologies,
Gaithersburg, MD, U.S.A.
Invitrogen, Carlsbad, CA, U.S.A.
Kahn and Hanawalt 1979
M. Sasser
Cuppels 1986
Yuan and He 1996
This work
Stratagene, La Jolla, CA, U.S.A.
Kovach et al. 1995
Jamir et al. 2004
Jamir et al. 2004
Jamir et al. 2004
Invitrogen. Carlsbad, CA, U.S.A.
Huang et al. 1988
Labes et al. 1990
Keen et al. 1988
Mackey et al. 2002
Jamir et al. 2004
Espinosa et al. 2003
Jamir et al. 2004
Jamir et al. 2004
Jamir et al. 2004
Jamir et al. 2004
Jamir et al. 2004
Petnicki-Ocwieja et al. 2002
Guo et al. 2005
Jamir et al. 2004
Jamir et al. 2004
Guo et al.
Jamir et al. 2004
Jamir et al. 2004
Jamir et al. 2004
This work
Jamir et al. 2004
(continued on following page)

Nalr, Rif r, Cmr, Spr, Apr, Gmr, Kmr, and Tcr = resistant to nalidixic acid, rifampicin, chloramphenicol, spectinomycin, ampicillin, gentamycin, kanamycin,
and tetracycline.
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urgency to identify specific plant targets and sites of action for
type III effectors. We are pursuing a line of experimentation to
do this for several of the type III effectors demonstrated to
suppress plant immunity. The identification of plant targets for
type III effectors promises to reveal key strategies for bacterial
pathogenesis and important undiscovered components of innate immunity.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions.
The bacterial strains and DNA constructs are listed in Table
2. E. coli and Agrobacterium strains were grown in Luria-Bertani (LB) medium at 37 and 30°C, respectively, with the appropriate antibiotics. Pseudomonas strains were cultured in
King’s B (KB) medium at 30°C with antibiotics. The concentrations (μg ml–1) of antibiotics used in the experiments are as
follows: ampicillin, 100; rifampicin, 100; kanamycin, 50; tetracycline, 20; spectinomycin, 50; gentamicin, 10; and nalidixic
acid, 100.
DNA manipulation.
Restriction enzymes, T4 DNA ligase, and Taq DNA polymerase were purchased from New England Biolabs (Beverly,
MA, U.S.A.). Thermostable Pfu DNA polymerase (Stratagene,
La Jolla, CA, U.S.A.) was used to amplify DNA fragments for

cloning. Primers listed in Table 3 were ordered from Integrated
DNA Technologies (Coralville, IA, U.S.A.). For Gateway
cloning, target DNA fragments were amplified by polymerase
chain reaction (PCR) using Pfu DNA polymerase and were
cloned into pENTR/D-TOPO (Invitrogen, Carlsbad, CA,
U.S.A.) following the manufacturer’s instructions. pENTR
constructs were recombined with Gateway Destination vectors
by LR reactions using LR Clonase purchased from Invitrogen.
For construction of pLN1965, which lacks the shcA/hopA1
operon, a 2.3-kb DNA fragment upstream of shcA was amplified by PCR from pHIR11, using primers P1892 and P0023,
and was cloned into the XbaI and EcoRI sites of pBluescript
KS+, resulting in construct pLN1949. Primers P0227 and
P0228 were used to PCR-amplify a 1.5-kb DNA region downstream of hopA1 from pHIR11, and the amplified product was
cloned into the XhoI and KpnI sites of pLN1949 resulting in
construct pLN1952. An omega cassette containing a spectinomycin-resistant gene was isolated from pHP45 by digestion
with EcoRI and was cloned into pLN1952 at the EcoRI site
within pLN1952, resulting in pLN1954, which was electroporated into E. coli C2110(pHIR11). The resulting strain was
grown in LB medium containing tetracycline and spectinomycin at 30°C, which was then switched to 37°C for selection of
recombination events. The pHIR11 derivatives that had undergone marker exchange were selected for based on spectinomycin resistance and ampicillin sensitivity and were confirmed

Table 2. (continued from previous page)
Strain or plasmid
pLN567
pLN592
pLN615
pLN677
pLN682
pLN683
pLN685
pLN686
pLN687
pLN734
pLN745
pLN746
pLN1154
pLN1156
pLN1323
pLN1324
pLN1326
pLN1327
pLN1328
pLN1329
pLN1331
pLN1419
pLN1420
pLN1528
pLN1622
pLN1623
pLN1624
pLN1636
pLN1906
pLN1949
pLN1952
pLN1954
pLN1965
pLN2423

Characteristicsa
pML123 derivative carrying hopT1-2-flag, Gmr
pLN462 derivative carrying hopAO1, Spr
pML123 derivative gateway destination vector containing a HA tag for C-terminal
fusions, Gmr Cmr
pBBR1MCS5 derivatived gateway destination vector containing a HA tag for Cterminal fusions, Gmr Cmr
pLN677 derivative carrying hopE1, Gmr
pLN677 derivative carrying shcF/hopF2 operon, Gmr
pLN677 derivative carrying avrPtoB, Gmr
pLN677 derivative carrying hopAM1, Gmr
pLN677 derivative carrying hopX1, Gmr
pLN1636 derivative containing a 2.0 kb downstream region of fliR. Apr Spr
pLN734 derivative containing a 1.5 kb upstream region of fliR. Apr Spr
pRK415 derivative containing a 1.5 kb upstream region, a Spr Ω cassette, and a 2.0-kb
downstream of fliR, Tcr Spr
pLN615 derivative carrying hopR1, Gmr
pLN615 derivative carrying shcM/hopM1, Gmr
pLN615 derivative carrying shcA/hopA1 from DC3000, Gmr
pLN615 derivative carrying shcN/hopN1, Gmr
pLN615 derivative carrying hopAA1-1, Gmr
pLN615 derivative carrying avrPto1, Gmr
pLN615 derivative carrying hopAS1′, Gmr
pLN615 derivative carrying hopAN1, Gmr
pLN615 derivative carrying hopAQ1, Gmr
pLN615 derivative carrying hopAA1-2, Gmr
pLN615 derivative carrying shcF/hopF2, Gmr
pLN615 derivative carrying hopY1, Gmr
pLN615 derivative carrying shcO/hopO1-1, Gmr
pLN615 derivative carrying shcO/hopO1-2, Gmr
pLN615 derivative carrying shcS2/hopS2, Gmr
pBluescript KS- containing Sp resistance Ω cassette at Hind III site. Apr Spr
pDSK509 derivative carrying avrRpt2, Kmr
pBluescript II KS+ derivative carrying a 2.3-kb fragment upstream of shcA in
pHIR11, Apr
pBluescript II KS+ derivative carrying both a 2.3-kb fragment upstream of shcA and
1.5 kb fragment downstream of hopA1 in pHIR11, Apr
pBluescript-II KS+ derivative carrying both a 2.3-kb fragment upstream of shcA, an
omega Sp resistant gene cassette, and 1.5-kb fragment downstream of hopA1 in
pHIR11, Apr Spr
pHIR11 derivative containing a deletion of shcA/hopA1 operon that is replaced with
Sp resistant gene cassette, Tcr Spr
pLN615 derivative carrying avrE1, Gmr

Reference or source
Guo et al. 2005
Espinosa et al. 2003
This work
Petnicki-Ocwieja et al. 2005
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
Vol. 22, No. 9, 2009 / 1077

using PCR and digestion with restriction enzymes. One of these
derivatives that lacked shcA/hopA1 and contained the spectinomycin omega cassette was designated pLN1965. This construct
was introduced into P. fluorescens 55 by triparental mating.
Construction of a DC3000 fliR hrcC double mutant.
We used homologous recombination to delete the fliR gene
in the DC3000 hrcC mutant. To do this, a 2.0-kb downstream
region of fliR was amplified with primers P1070 and P1071
and was cloned into pLN1636 in the XhoI and KpnI restriction
enzyme sites resulting in pLN734. A 1.5-kb upstream region of
fliR was amplified with primers P1080 and P1081 and was
cloned into pLN734 in the BamHI and EcoRV sites resulting
in construct pLN745. A fragment containing the fliR flanking
regions with an Ω fragment between them was cut out using
XhoI and EcoRV and was cloned into pRK415, resulting in
construct pLN746. pLN746 was transformed into the DC3000
hrcC mutant by electroporation. Homologous recombination in
the fliR region was selected using spectinomycin and screening
for loss of tetracycline resistance by growing a DC3000
hrcC(pLN746) culture for 5 days. Each day a new culture was
inoculated using the fresh overnight culture in KB medium
containing spectinomycin. The DC3000 fliR hrcC mutant,
designated UNL142, was confirmed using PCR.
Protein manipulation and immunoblots.
Leaf disks of transgenic and wild-type plants were harvested
with a 0.64-cm2 cork borer and were ground in liquid nitrogen.
The ground tissues were resuspended with 100 μl of 1.5× sodium dodecyl sulfate (SDS) sample buffer, followed by centrifugation for 5 min at 14,000 rpm. The decanted supernatant

was subjected to SDS–polyacrylamide gel electrophoresis. The
proteins were transferred to PVDF (polyvinylidene difluoride)
membranes (Milipore, Billerica, MA, U.S.A.). Anti-HA primary
antibodies (Roche, Basal, Switzerland) were used to detect HA
fusion proteins bound on PVDF membranes. Secondary antibodies used in immunoblots were anti–rat immunoglobulin G
alkaline-phosphatase conjugates (Sigma Chemical Co., St.
Louis). Proteins on immunoblots were visualized using the
CDP-Star chemiluminescence detection kit (Tropix, Bedford,
MA, U.S.A.) followed by autoradiography.
Transgenic Arabidopsis plants.
The Agrobacterium binary constructs pLN592 and pLN525,
which constitutively express hopAO1-ha and hopF2-ha, respectively, were electroporated into Agrobacterium tumefaciens C58C1. The resulting strains were used for Arabidopsis
floral-dipping transformation. Transgenic lines were selected
on Murashige-Skoog plates for kanamycin resistance. The expression of transgenes was detected by immunoblot using antiHA antibodies. Transgenic plant lines with high and stable
expression of HopAO1-HA or HopF2-HA were used in experiments.
Plant HR assay.
The DC3000 type III effector genes to be tested in P. fluorescens HR assays were cloned into pENTR/D-TOPO and
were then recombined with pLN615, a pML123 destination
vector that expresses C-terminal HA-tagged proteins (Table 2).
The resulting constructs were electroporated into P. fluorescens
(pHIR11). Bacterial strains grown on KB plates were resuspended at 1 × 108 cells/ml in 5 mM MES (morpholineethane-

Table 3. Primers for plasmid constructs
Gene name

Construct

Primers

Sequence

avrE1

pLN1098

avrPto1

pLN307

shcA/hopA1

pLN1028

shcA/hopA1

pLN1965

shcF/hopF2

pLN536

shcM/hopM1

pLN1464

shcN/hopN1

pLN1070

hopR1

pLN1133

hopY1

pLN1491

hopAA1-1

pLN887

HopAA1-2

pLN888

hopAI1

pLN1011

hopAN1

pLN1007

hopAQ1

pLN1015

hopAS1

pLN1009

fliR

pLN746

P1127
P1131
P689
P690
P755
P758
P0023
P0227
P0228
P1892
P680
P682
P1108
P1128
P1110
P1129
P1415
P634
P1713
P1714
P1230
P1231
P1202
P1203
P1322
P1323
P1314
P1315
P1310
P1311
P1318
P1319
P1070
P1071
P1080
P1081

5′-CACCACAGAGAGATTAACAGTGCAGTCACCATC-3′
5′-CTCTTCAGTTCGAACCCCTCTTTCTTCAAG-3′
5′-CACCTGTACTAAAGAGGGTATAAGAATGGGA-3′
5′-TTGCCAGTTACGGTACGGGCT-3′
5′-CACCGTTGATGAGCAGAACAATGAGCAAC-3′
5′-TTTCGTGTTTCGAAGGGCCGG-3′
5′-ATGAGAATTCGCATCTCCATGCATCTT-3′
5′-CGGACTCGAGCTCAGGGCGCGAAACTGA-3′
5′-GTATGGTACCCCGACCTGGCAACCGCAG-3′
5′-AGTCTCTAGAGGTGCTATCCACGCAGCG-3′
5′-CACCACCTTAAATTATGAGGATATGAGG-3′
5′-GACCCTTTCGACCGGCACTTT-3′
5′-CACCCTCAGAGGCCTAACAATGACCAACAATGACCAG-3′
5′-ACGCGGGTCAAGCAAGCCCTC-3′
5′-CACCAATGAGCGGGGAATAACAATGCGGCCTGTCGAGGCA-3′
5′-TCGCAAGTGAAAGTCTGCTCTGGGCAC-3′
5′-CACCAGGAGTTTAATAATAACGATGGTCAAGG -3′
5′-CACGTTATCGAGTTCGCCCCA-3′
5′-CACCGCGATAAAGGGAGATGAAACAATGAAC-3′
5′-CTGGTAGTTGATGCCCGTGGCG-3′
5′-CACCGAACGAGAGGGAATAACAATGCACATCAAC-3′
5′-CGACCGCATAGGCCGAAACGG-3′
5′-CACCGACCGAGATAGAATAACAATGCACATCAACCAATC-3′
5′-CAAACGCCTGAGCTGAAACGG-3′
5′-CACCCCCATAAACAAAACAATGCTCGC-3′
5′-GCGAGTCCAGGGCGGTGGCATCAGC-3′
5′-CACCGCGACCGACCTGGCAACAATGCTGGTGC-3′
5′-GGCTTCTCCCGCCAATTGCTTGAG-3′
5′-CACCCAAAGAGGTTTAACAATGAATCGAATTTC-3′
5′-TGCACTGCCACCAGCAATCGAGCG-3′
5′-CACCCGATGGAGCCCAACAATGACCTTAAG-3′
5′-AGAAAACTCGGCTTTCTGTTCAACC-3′
5′-ATGACTCGAGGCTCGTTGAGATGGCAG A-3′
5′-ATGAGGTACCTGCTGAAAGATACCGACC-3′
5′-ATGAGGATCCCACATGCGCCCTGGCGATG-3′
5′-ATGAGATATCGGTACTGATCTGGATATCGGTCAG-3′
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sulfonic acid), pH 5.6; three fivefold serial dilutions were
made, and each dilution was infiltrated into Nicotiana tabacum
cv. Xanthi leaves side by side with the vector control strain P.
fluorescens(pHIR11 + pML123). HR responses were recorded
24 to 48 h after infiltration.
Callose deposition assay.
To induce callose deposition wild-type A. thaliana Col-0 or
transgenic plants were infiltrated with 1 μM flg22 or flg22At
(flg22 from Agrobacterium, which is not recognized by FLS2
in Col-0). Alternatively, they were infiltrated with either the
hrcC mutant or the hrcC fliR double mutant. In an additional
strategy, we expressed AvrPtoB (pLN685), HopE1 (pLN682),
HopF2 (pLN683), HopX1 (pLN687), HopAM1 (pLN686), and
pBBR1MCS-5 (vector) in P. fluorescens(pLN1965). The suspensions of the strains were infiltrated into Col-0 at 1 × 107
cells/ml. For the experiments to determine if the type III effectors suppress callose deposition induced by AvrRpm1, pLN685
(AvrPtoB), pLN682 (HopE1), pLN683 (HopF2), pLN686
(HopAM1), pLN687 (HopX1), and pBBR1MCS-5 were electroporated into P. fluorescens(pLN1965) harboring
pVSP61::avrRpm1. The resulting strains were infiltrated into
A. thaliana Col-0 at a rate of 1 × 106 cells/ml. To determine the
levels of callose deposition 16 h after infiltration, leaf samples
were cleared with an alcoholic lactophenol solution, followed
by a rinse in 50% ethanol and a rinse in water as described
(Adam and Somerville 1996). The completely cleared leaves
were stained with 0.01% (wt/vol) aniline blue in a solution of
150 mM K2HPO4, pH 9.5, for 30 min. The callose deposits
were visualized with a fluorescence microscope (Zeiss Axionplan 2, Carl Zeiss, Oberkochen, Germany), and the number of
callose deposits was determined using Quantity One software
(Bio-Rad, Hercules, CA, U.S.A.).
In planta growth and pathogenicity assays.
Wild-type A. thaliana Col-0 or transgenic plants were grown
in a growth chamber at 24°C with 10 h of light per day. Bacterial growth in Col-0 and transgenic plants was determined by
spray-inoculating A. thaliana leaves with DC3000 or the
DC3000 type III–defective hrcC mutant. In some instances,
plants were pretreated with flg22 by infiltration of either 1 μM
flg22 or 1 μM flg22At. Plants were spray-inoculated with bacterial suspensions 12 h after pretreatment. The ability of bacteria to grow in planta was determined as described previously
(Espinosa et al. 2003). Briefly, four leaf disks were harvested
with a 0.4-cm2 cork borer 0 and 4 days after inoculation. The
samples were macerated in 250 μl of sterile water for 1 min
and were serially diluted. Each dilution (20 μl) was plated on
KB medium containing the appropriate antibiotics. The colonies recovered after 48 h on plates were enumerated.
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